Firstly, combined treatment with U0126 and VBT resulted in a synergistic effect in the reduction of cell surface expression of PDGFRA compared to U0126 treatment alone in the glioma cell lines #2, #3 and #5 with high surface PDGFRA expression (Figure 6E). Here, PDGFRA is linked to central nervous system cancer.